Expression of non-signaling membrane-anchored death receptors protects murine livers in different models of hepatitis
Expression of non-signaling membrane-anchored death receptors protects murine livers in different models of hepatitis
复制标题
DOI:
10.1002/hep.21257
复制
发表时间:
2006-08-01
期刊:
影响因子:
13.5
通讯作者:
Benihoud, Karim
中科院分区:
文献类型:
--
作者:
Descamps, Delphyne;Vigant, Frederic;Benihoud, Karim
Fas and tumor necrosis factor receptor 1 (TNFR1) are death receptors involved in various diseases such as hepatitis, sepsis, or graft rejection. Neutralizing antibodies to death ligands or soluble death receptors can inhibit cell death; however, they induce side effects because of their systemic actions. To specifically block death signaling to target cells, we created death domain-deficient (Delta DD) membrane-anchored receptors, delivered to the liver by either recombinant adenovirus or hydrodynamic pressure of nonviral recombinant plasmids. In anti-Fas antibody-induced fulminant hepatitis, mice expressing recombinant Fas-decoy receptors (Fas Delta DD) in their livers were completely protected against apoptosis and survived fulminant hepatitis. In T-cell-dependent concanavalin A-induced autoimmune hepatitis, Fas Delta DD antagonist expression prevented hepatocyte damage and mouse death. Finally, TNF1 Delta DD effectively protected mice against LPS-induced septic shock. In conclusion, such Delta DD-decoy receptors act as dominant-negative receptors exerting local inhibition, while avoiding systemic neutralization of apoptosis ligands, and might have therapeutic potential in hepatitis.